Biologics / Biotechnology

#Biologics / Biotechnology #Investment #Swiss Biotech Report

Swiss biotech sector sees strong performance in 2021, report says   

Switzerland’s life sciences sector saw a strong year in 2021 with companies contributing to the Covid-19 pandemic and high levels of capital investments being key indicators of the sector’s strength.   This is according to the latest edition of the Swiss Biotech Report1 which was launched by the Swiss Biotech Association.  … Read More

#Business & Investment #News

#Biologics / Biotechnology #mRNA #SLAS Europe

The shape of things to come

By DDW Editor-in-Chief Lu Rahman What a difference a year makes. It only feels like a few weeks ago that we were looking forward to SLAS2022 and now we have SLAS Europe on the horizon. How welcome it is to be back in the swing of face-to-face events again compared… Read More

#Exclusive Content

#Biologics / Biotechnology #Biosciences #Lab space #Open Cell

Interview: How this ‘hotel for scientists’ offers opportunity for biotech start-ups 

Open Cell, a ‘hotel for scientists’ in London, UK, provides a cluster of small labs within a large shipping container facility, that are available for short-term rental by biotech startups with a range of shared services and facilities. As well as private labs, the facilities provide access to equipment worth… Read More

#Exclusive Content #Intelligence #News #Opinion

Stem cells
#Biologics / Biotechnology #Immunology / Virology & Vaccines #Stem cells

Podcast: Is customisation healthcare’s secret weapon? 

This is the latest episode of the free DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW.  The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual… Read More

#News

Stem cells
#Biologics / Biotechnology #Immunology / Virology & Vaccines #Narrated podcasts #Stem cells

Is customisation healthcare’s secret weapon? 

This is the latest episode of the free narrated DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Optimising vaccine production through… Read More

#Podcasts

#Biologics / Biotechnology #Cancer immunotherapy #Drug discovery #Flow Cytometry #Immuno-oncology #Webinar

Webinar offers insight into pharmacological reactions

Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More

#News #Trending News

#Biologics / Biotechnology #Cancer immunotherapy #Drug discovery #Flow Cytometry #Immuno-oncology #Webinar

Are you investigating pharmacological reactions?

Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More

#News

#Biologics / Biotechnology

Discover a new data landscape with Zeno 

This paid-for advertorial by AB Sciex appeared in DDW Volume 22, Issue 4 – Fall 2021  This high-resolution accurate mass system combines the power of Zeno trap pulsing with EAD fragmentation technology (electron activated dissociation) to uncover structural information, previously inaccessible, and drive the limits of quantification achievable with accurate… Read More

#Exclusive Content

#Biologics / Biotechnology #Cell painting #Collaboration #Drug discovery #Phenomics #Podcast

Recipe for success: collaboration in drug discovery – podcast 

The latest free-to-listen DDW podcast episode is titled “Recipe for success: collaboration in drug discovery”. It covers three articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine, narrated by DDW’s Megan Thomas.  These articles are titled: “Why collaboration matters and… Read More

#Editor's Choice #News

#Biologics / Biotechnology #Collaboration #Drug development

Collaboration aims to accelerate cyro-EM research 

Amgen and the University of Southern California (USC) are working together to provide researchers access to two cryo-transmission electron microscopes (cryo-EMs) – the Thermo Scientific Krios and Glacios.  Access to the two instruments in one shared location allows researchers from both institutions to combine resources to bring more speed and… Read More

#News

#Biologics / Biotechnology #Covid-19 #HIV #In vivo #Therapeutics

Biotech start-up takes another stride toward flu cure 

Covimro, a British biotech start-up, has developed a food-grade compound which has demonstrated its efficacy against the flu virus in an animal model study carried out by A-IR Clinical Research and Pharmidex Pharmaceutical Services.  The in vivo testing analysed Covimro’s antiviral capability against an infection of Influenza A H3N2, a flu variant consistent with… Read More

#News #Start-up Zone

#Biologics / Biotechnology #Biomedicine #Drug discovery #Imaging #PET technology #Radiochemistry

MDC relaunches Wolfson radiochemistry facility

Medicines Discovery Catapult (MDC) has relaunched radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) at the University of Manchester, UK. The facility, which was closed in 2020, includes the multi-million pound ‘Cyclotron’, one of only a few in the UK. It will supply radio-chemicals to drug discovery biotechs and academics,… Read More

#News

#Biologics / Biotechnology #Biotechnology #Covid-19 #Life sciences #Public health

Europe’s emerging biotechs: Challenges, opportunities and funding

Listen to this article on the DDW Podcast: John Macdonald is Vice President, Venture & Financial Alliances at ICON. He examines the European biotech sector – its expertise and opportunities and potential for growth. By harnessing biological processes on a cellular and biomolecular level, biotech is benefitting industries as varied as… Read More

#Business & Investment #Covid-19 #Editor's Choice #Exclusive Content #Market Reports #News #Opinion

#Biologics / Biotechnology #CAR-T #Cell therapy #Immunotherapy #Stem cells

Biotech’s pursuit of next-generation CAR-T

Listen to this article on the DDW Podcast: Pierre-Louis Joffrin leads Corporate Development at Mogrify. He examines immunotherapies including an assessment of the next generation of stem cell derived products. Biotech has joined the pursuit of next-generation CAR-Ts and it’s not subtle. Some new, others having pivoted towards the area, there… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News

#Biologics / Biotechnology #Bioscience #Biotechnology #Drug delivery #Drug development #Drug discovery

Switzerland: punching above its weight as global biotech hub

Listen to this article on the DDW Podcast:   To understand Switzerland’s continued success in the biotech sector and gain personal insights, Lu Rahman spoke to Michael Altorfer (CEO of the Swiss Biotech Association), Jan Lucht (Head of Biotechnology, scienceindustries), Claude Joris (Secretary General, BioAlps), and Carole Delauney (Business Development Director… Read More

#Editor's Choice #Exclusive Content #Market Reports #News

#AstraZeneca #Biologics / Biotechnology #Clinical trials #Drug delivery #Drug development #Pharma

Chinese/Western partnership to promote indigenous drugs

Chinese biopharma companies are eyeing strategic collaborations with Western counterparts to leverage their networks and commercial capabilities to promote indigenously developed drugs in China, says GlobalData, a data and analytics company. China-based Luye Pharma Group’s holding subsidiary Boan Biotech signed an agreement with AstraZeneca China in May 2021 regarding the… Read More

#Market Reports #News #Trends & Analysis